Sign In
Free Newsletter
Trump administration chooses RVA pharma startup for $354M COVID-19 contract
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India. […]
Richmond pharmaceutical company expands into Canada
Richmond-based pharmaceutical company Kaléo announced Wednesday it is expanding its market to Canada, offering its epinephrine auto-injector Allerject. The product used to treat severe allergic reactions will be available in pharmacies across Canada starting May 19. In response to a shortage of EpiPen in Canada in 2018, Kaléo’s original epinephrine auto-injector Auvi-Q was available in [[...]
